Cited by — Real-world use of multiplex point-of-care molecular testing or laboratory-based molecular testing for influenza-like illness in a 2021 to 2022 US outpatient sample | ResearchHub - ResearchHub
Research graph
Cited by
Admitted local publications that cite Real-world use of multiplex point-of-care molecular testing or laboratory-based molecular testing for influenza-like illness in a 2021 to 2022 US outpatient sample.
No admitted local citation edges point to this work yet.
